Studies have found that about 5.6% of multi-dose medication vials, like semaglutide, develop bacterial growth over time
Providers that offer coverage for branded semaglutide may also offer coverage for compounded semaglutide in limited cases
(Hims & Hers, NYSE: HIMS), the leading health and wellness platform, today shared more data on the challenges Americans are facing when trying to access branded GLP-1 medication and introduced a GLP-1 Supply Tracker, where individuals can be a part of advocating for better access to the medications they need
Osteoblast-derived cells express functional glucose-dependent insulinotropic peptide receptors
These patient stories unravel the varied pathways individuals navigate when confronted with novel vs
Always confirm current pricing and state availability directly with the provider before starting treatment